ImmunoPhotonics

ImmunoPhotonics

An immuno-oncology company developing a novel drug for use in an in situ autologous cancer vaccine (inCVAX) for the treatment of metastatic cancer.

Area of focus: 
Oncology
Commencement date: 
03/15/2016

Share